Navigation Links
Hope for Alzheimer's blossoms

A substance found in the Welsh national flower, which could offer hope for sufferers of Alzheimer's disease, is being supported for large scale manufacture by Cardiff University's Manufacturing Engineering Centre (MEC).

Alzheimer's disease is the most common form of dementia, making up 55 per cent of all cases of dementia. Dementia affects one person in 20 over the age of 65 and one person in five over the age of 80.

Certain species of daffodil, which thrive in the Black Mountains of South Powys, produce galanthamine, a leading drug in the alleviation of memory loss symptoms.

The University's Manufacturing Engineering Centre is now helping a company Alzeim Ltd (supported by Glasu, the EU funded LEADER+ Programme in Powys) to develop the agricultural potential of the daffodil as a medicinal plant along with the Institute of Grassland and Environmental Research at the University of Wales, Aberystwyth.

The Centre is providing support from harvesting in the field to marketing the pharmaceutical product. This includes assisting with the science of developing crops more than once a year and helping growers to assess when the best time to harvest the crop.

Frank Marsh, Marketing Director, The Manufacturing Engineering Centre said: "Galanthamine has major investment potential. Furthermore, the potential for Welsh hill farms is huge. The benefits are extensive, not only to Welsh bioscience and the pharmaceutical industry, but also to the ageing population."


'"/>

Source:Cardiff University


Page: 1

Related biology news :

1. Neuronal traffic jam marks early Alzheimers disease
2. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
3. Gene vaccine for Alzheimers disease shows promising results
4. Duke Chemists Isolating Individual Molecules Of Toxic Protein In Alzheimers, Parkinsons Disease
5. Nanoscale Diagnostic Sets Sights on Alzheimers
6. Alzheimers cognitive decline slowed
7. One gene links newborn neurons with those that die in diseases such as Alzheimers
8. Scientists discover that three molecules may be developed into new Alzheimers drugs
9. Pinpointing a culprit molecule in Alzheimers disease
10. Targeting a key enzyme with gene therapy reversed course of Alzheimers disease in mouse models
11. Natural compound from pond scum shows potential activity against Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... 27, 2016 Research and Markets has announced ... report to their offering. ... to grow at a CAGR of 12.28% during the ... on an in-depth market analysis with inputs from industry experts. The ... coming years. The report also includes a discussion of the key ...
(Date:6/22/2016)... American College of Medical Genetics and Genomics was once again ... of the fastest-growing trade shows during the Fastest 50 Awards ... Las Vegas . Winners are ... of the following categories: net square feet of paid exhibit ... 2015 ACMG Annual Meeting was ranked 23 out of 50 ...
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016  Alex,s Lemonade Stand Foundation (ALSF), ... it will open a state-of-the-art bioinformatics lab, using ,big ... This announcement comes as Liz Scott , co-executive ... Cancer Moonshot Summit in Washington, D.C. ... a participant and advocate of pediatric cancer research and ...
(Date:6/27/2016)... , June 27, 2016  Global demand for ... percent through 2020 to $7.2 billion.  This market ... beverages, cleaning products, biofuel production, animal feed, and ... diagnostics, and biocatalysts). Food and beverages will remain ... by increasing consumption of products containing enzymes in ...
(Date:6/27/2016)... /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") ... shareholders, Clean Technology Fund I, LP and Clean Technology ... based venture capital funds which together hold approximately 59% ... diluted, as converted basis), that they have entered into ... holdings in Biorem to TUS Holdings Co. Ltd. ("TUS") ...
(Date:6/27/2016)... June 27, 2016  Sequenom, Inc. (NASDAQ: ... healthier lives through the development of innovative products and ... the United States denied its petition ... claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") ... established by the Supreme Court,s Mayo Collaborative Services v. ...
Breaking Biology Technology: